Clinical Trial: Efficacy of Low-dose PT-Cy for Prevention of GVHD in Ambulatory Allogeneic HSCT

U.S., Jan. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07319000) titled 'Efficacy of Low-dose PT-Cy for Prevention of GVHD in Ambulatory Allogeneic HSCT' on Sept. 08, 2025.

Brief Summary: Low-dose post-transplant cyclophosphamide have demonstrated therapeutic efficacy in allogeneic stem cell transplants which is comparable with the standard dose and also facilitates early hematological recovery.

Study Start Date: Jan. 01, 2023

Study Type: INTERVENTIONAL

Condition: Graft Versus Host Disease

Intervention: DRUG: Cyclophosphamide

low-dose post-transplant cyclophosphamide

Recruitment Status: COMPLETED

Sponsor: Hospital Universitario Dr. Jose E. Gonzalez

Information provided by (Responsible Party): Ce...